These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 34857523)
21. The Global Interest in Vaccines and Its Prediction and Perspectives in the Era of COVID-19. Real-Time Surveillance Using Google Trends. Sycinska-Dziarnowska M; Paradowska-Stankiewicz I; Woźniak K Int J Environ Res Public Health; 2021 Jul; 18(15):. PubMed ID: 34360134 [TBL] [Abstract][Full Text] [Related]
22. Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19). Khouja T; Mitsantisuk K; Tadrous M; Suda KJ J Antimicrob Chemother; 2022 Apr; 77(5):1491-1499. PubMed ID: 35178565 [TBL] [Abstract][Full Text] [Related]
23. More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry's Role in Widening the Access Gap. Borges LC; Zeferino de Menezes H; Crosbie E Int J Health Policy Manag; 2022 Dec; 11(12):3101-3113. PubMed ID: 36028975 [TBL] [Abstract][Full Text] [Related]
24. Disparities in COVID-19 clinical studies from high-income and low-and middle-income countries. Yin S; Ren J; Xue J; Li P; Luo J; Yin J; Luo L; Li Z; Luo G Int J Infect Dis; 2023 Jul; 132():9-16. PubMed ID: 37068582 [TBL] [Abstract][Full Text] [Related]
25. Which roads lead to access? A global landscape of six COVID-19 vaccine innovation models. Alonso Ruiz A; Bezruki A; Shinabargar E; Large K; Vieira M; Slovenski I; Liu Y; Agarwal S; Becker A; Moon S Global Health; 2024 Mar; 20(1):25. PubMed ID: 38532484 [TBL] [Abstract][Full Text] [Related]
26. Impact of mRNA vaccines in curtailing SARS-CoV-2 infection and disability leave utilisation among healthcare workers during the COVID-19 pandemic: cross-sectional analysis from a tertiary healthcare system in the Greater Houston metropolitan area. Vahidy FS; Pan AP; Hagan K; Bako AT; Sostman HD; Schwartz RL; Phillips R; Boom ML BMJ Open; 2021 Oct; 11(10):e054332. PubMed ID: 34642201 [TBL] [Abstract][Full Text] [Related]
27. Challenges of COVID-19 in children in low- and middle-income countries. Zar HJ; Dawa J; Fischer GB; Castro-Rodriguez JA Paediatr Respir Rev; 2020 Sep; 35():70-74. PubMed ID: 32654854 [TBL] [Abstract][Full Text] [Related]
28. SARS-COV-2 Vaccines: What Indicators are Associated with the Worldwide Distribution of the First Doses. Sobral MFF; Bezerra de Oliveira BR; Gomes da Penha Sobral AI; Monteiro Marinho ML; Duarte GB; de Souza Melo A Inquiry; 2021; 58():469580211060184. PubMed ID: 34823403 [TBL] [Abstract][Full Text] [Related]
29. State capture through indemnification demands? Effects on equity in the global distribution of COVID-19 vaccines. Gorodensky A; Kohler JC J Pharm Policy Pract; 2022 Aug; 15(1):50. PubMed ID: 35986397 [TBL] [Abstract][Full Text] [Related]
30. Interrupted time series analysis of Canadian legal cannabis sales during the COVID-19 pandemic. Armstrong MJ; Cantor N; Smith BT; Jesseman R; Hobin E; Myran DT Drug Alcohol Rev; 2022 Jul; 41(5):1131-1135. PubMed ID: 35316855 [TBL] [Abstract][Full Text] [Related]
31. Cost of vaccine delivery strategies in low- and middle-income countries during the COVID-19 pandemic. Banks C; Portnoy A; Moi F; Boonstoppel L; Brenzel L; Resch SC Vaccine; 2021 Aug; 39(35):5046-5054. PubMed ID: 34325935 [TBL] [Abstract][Full Text] [Related]
32. Equitable access to COVID-19 vaccines makes a life-saving difference to all countries. Ye Y; Zhang Q; Wei X; Cao Z; Yuan HY; Zeng DD Nat Hum Behav; 2022 Feb; 6(2):207-216. PubMed ID: 35102361 [TBL] [Abstract][Full Text] [Related]
33. [Routine immunization 2020 in Chile during the SARS-CoV-2 pandemic]. Bastías M; Brstilo I; González C Rev Chilena Infectol; 2021 Jun; 38(3):355-361. PubMed ID: 34479292 [TBL] [Abstract][Full Text] [Related]
34. Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020-2022. Nandi A; Pecetta S; Bloom DE EClinicalMedicine; 2023 Mar; 57():101848. PubMed ID: 36776504 [TBL] [Abstract][Full Text] [Related]
35. Health inequality among different economies during early phase of COVID-19 pandemic. Aung MN; Koyanagi Y; Yuasa M J Egypt Public Health Assoc; 2021 Feb; 96(1):3. PubMed ID: 33595767 [TBL] [Abstract][Full Text] [Related]
36. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
37. Impact of the COVID-19 pandemic on patients with paediatric cancer in low-income, middle-income and high-income countries: a multicentre, international, observational cohort study. Global Health Research Group on Children’s Non-Communicable Diseases Collaborative BMJ Open; 2022 Apr; 12(4):e054690. PubMed ID: 35410925 [TBL] [Abstract][Full Text] [Related]
38. COVID-19 Vaccine Hesitancy among the Public in Kuwait: A Cross-Sectional Survey. Alibrahim J; Awad A Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444585 [TBL] [Abstract][Full Text] [Related]
39. COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs. Nhamo G; Chikodzi D; Kunene HP; Mashula N Glob Public Health; 2021 Mar; 16(3):319-339. PubMed ID: 33317389 [TBL] [Abstract][Full Text] [Related]
40. Vaccine nationalism: a predicament in ending the COVID-19 pandemic. Lagman JDN J Public Health (Oxf); 2021 Jun; 43(2):e375-e376. PubMed ID: 33730161 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]